Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings.
about
Photoacoustic tomography: fundamentals, advances and prospectsInflammatory breast cancer: what we know and what we need to learnPreliminary in vivo breast vibro-acoustography results with a quasi-2-d array transducer: a step forward.Photoacoustic imaging: a potential tool to detect early indicators of metastasis.Breast metastasis of a squamous cell carcinoma of the uterine cervix mimicking inflammatory breast cancerSemiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant?Management of Rare Histological Types of Breast Tumours.Computed tomography Hounsfield units can predict breast cancer metastasis to axillary lymph nodes.International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatmentInflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer.Inflammatory Breast Carcinoma Presenting with Two Different Patterns of Cutaneous Metastases: Carcinoma Telangiectaticum and Carcinoma Erysipeloides.Current and future applications of magnetic resonance imaging (MRI) to breast and ovarian cancer patient management.Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy.Clinical impact of (18)F-FDG PET/CT on initial staging and therapy planning for breast cancer.Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.Initial evaluation of inflammatory breast cancer with fluorodeoxyglucose positron emission tomography.Radiological and clinical features of adult non-puerperal mastitisSpectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT.Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response?Special Relevance of FDG-PET as an Upfront Diagnostic Modality at Initial Diagnosis and in Suspected Recurrence in Patients of Breast Carcinoma Hailing From Lower Socioeconomic Status Owing to Relative Late Presentation: A Pilot Study in a Medical CBiology and management of inflammatory breast cancer.Can T2-weighted 3-T breast MRI predict clinically occult inflammatory breast cancer before pathological examination? A single-center experience.Clinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.Review of ultrasound appearance in inflammatory breast cancer: A pictorial essay.Present and future role of FDG-PET/CT imaging in the management of breast cancer.Clinical PET-MR Imaging in Breast Cancer and Lung CancerInflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research.Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms.Inflammatory breast cancer in a previously treated case of breast cancer: a diagnostic dilemma for the clinician.The role of PET and MRI in evaluating the feasibility of skin-sparing mastectomy following neoadjuvant therapy.Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Assessment of Inflammatory Breast Cancer Prior to and After Neoadjuvant Treatment.Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference.Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis.
P2860
Q27027215-13BB8A78-26B1-42A6-8986-8865B9F83B57Q27028128-6D90128A-D290-41D8-96EE-D6F6CAA6E348Q30397643-49227F28-841F-4E00-9388-053114AA8651Q30447713-93ABCB52-58C2-49E4-BB52-1481A607951EQ30462145-F470E15A-15E9-4371-8F64-02D1F207E5A2Q34026396-F7510C77-7A17-4B31-843F-B0C9AAB4F6B0Q34096348-1BD081A6-A589-40E9-8078-43FE31CAC621Q34320273-4CD9DDCF-4176-4945-9E79-977499A7B500Q35017523-62D420F8-82BD-4CF0-8CF8-49388094FE0DQ35115896-D9F05F77-B0D1-4843-822F-181BB9267DC0Q36020234-884EF44C-D8B6-49F3-BAFA-A085D7DCC661Q36197710-0942EBCF-0764-4262-B186-CF68A6114F82Q36324120-8085F3BA-1B90-4672-98E2-8681A85A90A2Q36409205-2B59B700-C569-4551-B7FE-BBA6C728BA58Q36476568-0352EBF7-ACC0-4445-8B1A-C09B1BBD3125Q36771799-507744A3-BE9A-48B0-A756-29D776E7B6DAQ36793606-442092AA-2662-421C-8C32-F494CDB3CD18Q36992771-4C28ACC0-90A9-4633-838C-B8C41AE4DC1DQ37035352-82468976-2FE1-44AB-B2FB-41F09846FC5AQ37660339-8062B3C5-533E-42C6-9EB5-C0F7ADD2CDC0Q37687382-793F859C-2020-4B66-8C5C-CA8C05E37E6CQ38056072-9CA582CD-7FE8-479D-919F-D88590A2493FQ38165388-9A28338F-16FC-48C7-A53D-76DD929190CCQ38657433-C35D6EE7-6B81-4428-ACC8-E281562211F6Q38687620-4D1DCEBF-3116-4523-893E-9087E3604F67Q38945974-2C368F76-0508-4944-80CE-34F6D3D7441DQ42745026-25B11439-DF14-4FAB-BA0A-2284143EA47AQ47188618-A0077FDF-F24B-467F-9F93-FFF9B6FBAB3FQ47442617-340AEFC4-A1B2-430C-89F2-D96082930413Q50052650-0C0C00CA-01D5-4B95-ADB5-77838AD87E4FQ50085556-8CCEA275-311F-42D4-B936-C04B4B2EB128Q51408712-35AE3CC3-FF1D-41CC-AE0E-A15A4A492299Q52714397-4DDDA5ED-ACEF-49DD-A70C-8E9532B3CA40Q54967454-164E2769-9B88-422A-8096-5B4DE155134BQ54976875-4E59091A-DDA0-4FED-9FDC-F167C0C723B9
P2860
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings.
@en
type
label
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings.
@en
prefLabel
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings.
@en
P2093
P1476
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings.
@en
P2093
Ana M Gonzalez-Angulo
Erika Resetkova
Gabriel N Hortobagyi
Homer Macapinlac
Huong T Le-Petross
Massimo Cristofanilli
Selin Carkaci
Shaheenah Dawood
Wei T Yang
P2888
P304
P356
10.1007/S10549-007-9671-Z
P407
P577
2007-07-26T00:00:00Z